- Home
- SLQT vs HUMA Comparison
SLQT vs HUMA Comparison
Compare SLQT & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLQT | HUMA |
|---|---|---|
| Founded | 1999 | 2004 |
| Country | United States | United States |
| Employees | N/A | 220 |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.6M | 229.7M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | SLQT | HUMA |
|---|---|---|
| Price | $0.61 | $0.78 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $2.88 | ★ $9.29 |
| AVG Volume (30 Days) | 1.4M | ★ 5.8M |
| Earning Date | 02-05-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 105.00 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $1,526,594,000.00 | N/A |
| Revenue This Year | $11.42 | N/A |
| Revenue Next Year | $7.76 | $731.05 |
| P/E Ratio | $61.98 | ★ N/A |
| Revenue Growth | ★ 15.50 | N/A |
| 52 Week Low | $0.60 | $0.81 |
| 52 Week High | $3.97 | $3.35 |
Technical Indicators
Market Signals| Indicator | SLQT | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 24.79 | 32.32 |
| Support Level | N/A | N/A |
| Resistance Level | $0.94 | $1.30 |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 6.04 | 14.52 |
Price Performance
Historical ComparisonAbout SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.